all report title image

MOSQUITO BORNE DISEASE MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Mosquito Borne Disease Market, By Disease Type (Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus, and Others), By Treatment Type (Medication, Vaccination, Vector Control Methods, Immunotherapy, Supportive Care, and Others), By End User (Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, NGOs, and Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In: 29 Apr, 2026
  • Code: CMI6241
  • Page number: 150
  • Formats:   Excel and PDF
  • Industry: Pharmaceutical
    • Historical Range : 2020 - 2024
    • Base Year : 2025
    • Estimated Year : 2026
    • Forecast Period : 2026-2033
Ingographics Image

Table of Contents (Version-2026)

  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Mosquito Borne Disease, By Disease Type
      • Market Mosquito Borne Disease, By Treatment Type
      • Market Mosquito Borne Disease, By End User
      • Market Mosquito Borne Disease, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
    • Impact Analysis
    • Key Highlights
    • Regulatory Scenario
    • Product Launches/Approvals
    • PEST Analysis
    • PORTER’s Analysis
    • Merger and Acquisition Scenario
  4. Global Mosquito Borne Disease Market, By Disease Type, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Malaria
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Dengue 
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Yellow Fever
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • West Nile Virus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Chikungunya
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Zika Virus
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  5. Global Mosquito Borne Disease Market, By Treatment Type, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Medication
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Vaccination
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Vector Control Methods
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bin)
    • Immunotherapy
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Supportive Care
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  6. Global Mosquito Borne Disease Market, By End User, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Hospitals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Clinics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Diagnostic Centers
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Research Institutes
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Government Organizations
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • NGOs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
  7. Global Mosquito Borne Disease Market, By Region, 2021 - 2033, (US$ Bn)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022 –2033
      • Country Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • U.S.
        • Canada
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • Germany
        • U.K.
        • Spain
        • France
        • Italy
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • Brazil
        • Argentina
        • Mexico
        • Rest of Latin America
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
        • GCC Countries
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Bn)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
        • South Africa
        • North Africa
        • Central Africa
  8. Competitive Landscape

    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Developments
      • Financial Performance
      • Strategies
    • Sanofi S.A.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Pfizer Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Merck & Co., Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Johnson & Johnson
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Eisai Co., Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Takeda Pharmaceutical Company Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • AstraZeneca
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Valeant Pharmaceuticals International, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mitsubishi Tanabe Pharma Corporation
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Abbott
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Hoffmann-La Roche Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sun Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Lupin Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • BioCryst Pharmaceuticals, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Mallinckrodt Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Serum Institute of India Pvt. Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • CSL Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Teva Pharmaceutical Industries Ltd
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Analyst Views
  9. Section

    • Research Methodology
    • About us

*Browse 46 market data tables and 42 figures on “Global Mosquito Borne Disease Market” - Global forecast to 2033

  • Need a Custom Report?

    We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

    Customize Now
Logo

Credibility and Certifications

DUNS Registered

860519526

ESOMAR
Credibility and Certification

9001:2015

Credibility and Certification

27001:2022

Clutch
Credibility and Certification

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo

© 2026 Coherent Market Insights Pvt Ltd. All Rights Reserved.